ICE3 Trial 3-Year Interim Results
Update: 2023-01-01
Description
In this episode of IOL Radio, we speak with Dr Kenneth Tomkovich. Dr Tomkovich is the co-principal investigator of the ICE3 trial, which was designed to evaluate the safety and efficacy of breast cryoablation, enabling women older than 60 years with low-risk early-stage breast cancers to benefit from a nonsurgical treatment and to avoid the associated surgical risks. He is here to discuss the 3 year interim analysis, which was recently published in the Annals of Surgical Oncology.
Learn more about the ICE3 trial here.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
